Although over 40% of the US population is currently comprised of ethnic and racial minorities, typically only 5% to 10% of clinical trial participants represent any minority population, and that ...

Results of Ideate-Lung01 trial at WCLC back up MSD and Daiichi Sankyo's decision to move anti-B7-H3 ADC I-Dxd into phase 3 for small cell lung cancer.